Clinical trial
Molecular Fingerprinting of Lung Cancer
NCT00897117 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Fingerprinting of Lung Cancer
- Lead sponsor
- Vanderbilt-Ingram Cancer Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 1, 2001
- Completion date
- May 31, 2031
- Enrollment
- 4,000 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer